| abstract |
The invention concerns novel biotinylated hexadecasaccharides of general formula (I) wherein: Biot is a biotin derivative; R, R 1 and R 2 , represent independently of one another a C 1 -C 6 alkoxy or and —OSO 3 ; R 3 represents a C 1 -C 6 alkoxy or an —OSO 3 , or R 3 constitutes a —O—CH 2 — bridge; Pe represents a saccharide concatenation; as well as their pharmaceutically acceptable salts, and their use as medicines. |